C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.

Saved in:
Bibliographic Details
Title: C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.
Authors: Pentón-Rol G; Center for Genetic Engineering and Biotechnology (CIGB), Ave. 31 e/158 y 190, Cubanacan, P.O. Box 6162, Playa, Havana 10600, Cuba. giselle.penton@cigb.edu.cu., Marín-Prida J; Center for Research and Biological Evaluations (CEIEB), Institute of Pharmacy and Food, University of Havana, Ave. 23 e/214 y 222, La Lisa, PO Box 430, Havana 13600, Cuba. jmarin@infomed.sld.cu., Falcón-Cama V; Center for Genetic Engineering and Biotechnology (CIGB), Ave. 31 e/158 y 190, Cubanacan, P.O. Box 6162, Playa, Havana 10600, Cuba. viviana.falcon@cigb.edu.cu.
Source: Behavioral sciences (Basel, Switzerland) [Behav Sci (Basel)] 2018 Jan 18; Vol. 8 (1). Date of Electronic Publication: 2018 Jan 18.
Publication Type: Journal Article; Review
Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101576826 Publication Model: Electronic Cited Medium: Print ISSN: 2076-328X (Print) Linking ISSN: 2076328X NLM ISO Abbreviation: Behav Sci (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first